Evidence map›Paper›PMID 33420247›Full record

ArticleScientific reports2021

Surgical outcomes after collagenase Clostridium histolyticum failure in patients with Peyronie's disease in a multicenter clinical study.

Andrea Cocci, David Ralph, Rados Djinovic, Georgios Hatzichristodoulou, Girolamo Morelli, Andrea Salonia, Paolo Capogrosso, Andrea Romano, Gianmartin Cito, Fabrizio Di Maida and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 6 countries.

Andrea CocciDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
David RalphSt. Peter's Andrology Centre and UCLH, London, UK.
Rados DjinovicSava Perovic Foundation, Center for Genito-Urinary Reconstructive Surgery, BelMedic General Hospital, Belgrade, Serbia.
Georgios HatzichristodoulouDepartment of Urology, Martha-Maria Hospital Nuremberg, Nuremberg, Germany.
Girolamo MorelliDepartment of Urology, Cisanello Hospital, University of Pisa, Pisa, Italy.
Andrea SaloniaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Paolo CapogrossoDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Andrea RomanoDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Gianmartin CitoDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Fabrizio Di MaidaDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Esaú Fernández-PascualLyx Institute of Urology, Universidad Francisco de Victoria, Madrid, Spain.
Javier Romero-OteroUrology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain.
Paulo EgydioPenile Curvature Center, São Paulo, Brazil.
Marco FalconeUrology Department, Città della Salute e della Scienza-Molinette Hospital, University of Turin, Turin, Italy.
Mirko PretoUrology Department, Città della Salute e della Scienza-Molinette Hospital, University of Turin, Turin, Italy.
Giovanni ChiriacòSt. Peter's Andrology Centre and UCLH, London, UK.
Jack BeckDepartment of Urology and Men's Health, St. Antonius Hospital Nieuwegein, Utrecht, The Netherlands.
Maarten AlbersenUniversity Hospitals Leuven, Leuven, Belgium.
Suks MinhasDepartment of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Giovanni CacciamaniUSC Institute of Urology and Catherine and Joseph Aresty Department of Urology, University of Southern California, Los Angeles, CA, USA.
Juan Ignacio Martinez SalamancaDepartment of Urology, Hospital Universitario Puerta De Hierro-Majadahonda, Madrid, Spain.
Nicola MondaniAndrology Center, Villa Donatello Private Hospital, Florence, Italy.
Andrea MinerviniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Giorgio Ivan RussoDepartment of Surgery, Urology Section, University of Catania, Catania, Italy. Giorgioivan1987@gmail.com.
University of Florence · ITIRCCS Ospedale San Raffaele · ITUniversity of Turin · ITCharing Cross Hospital · GBHospital Universitario 12 De Octubre · ESHospital Universitario Puerta de Hierro Majadahonda · ESMartha-Maria Hospital · DESt. Antonius Ziekenhuis · NLUniversidad Francisco de Vitoria · ESUniversity of Catania · ITUniversity of Pisa · ITUniversity of Southern California · USVilla Torri Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study we aimed to investigate the surgical outcomes of patients with persistent penile curvature (PC) after Collagenase Clostridium histolyticum (CCH) intraplaque injections. Data from 90 patients with persistent PC after CCH in a multicentre study from 6 andrological centres were retrospectively reviewed. Three standardized surgical techniques were performed. Group 1: plaque incision grafting (PIG) with penile prosthesis implant (PPI); Group 2: PIG without PPI; Group 3: Nesbit technique. Hospital stay, operative time, postoperative complications and PC persistency/recurrence (> 20°) were evaluated. Overall satisfaction and functional outcomes were assessed through International Index of Erectile Function-Erectile Function (IIEF-EF), Peyronie's Disease Questionnaire (PDQ), Female Sexual Function Index (FSFI) administered pre and 3 months postoperatively. Of all, 25 (27.8%) patients received grafting procedure + PPI (Group 1), 18 (20.0%) patients belonged to Group 2, and 47 (52.2%) to Group 3. Bovine pericardium graft and collagen fleece have been used in in 22 (51.2%) and 21 (48.8%) patients, respectively. Median penile length after surgery was 13.0 cm (IQR 12.0-15.0). After surgery, Group 1 showed higher increase in penile length after surgery and better improvements in terms of PDQ-PS. In contrast, both IIEF-EF and FSFI scores did not differ among groups. Overall, 86 (95.6%) did not report any complication. 4 (4.4%) patients had PC recurrence; of those, 2 (8.0%), 1 (5.6%) and 1 (2.1%) cases were observed in Group 1, Group 2 and Group 3, respectively. In case of persistent PC after CCH, surgical correction by grafting with or without concomitant PPI or Nesbit technique emerged as a technically feasible, effective and safe procedure, with no significant postoperative complications.

Indexed as

AdultHathewaya histolyticaHumansInjections, IntralesionalMaleMicrobial CollagenaseMiddle AgedPatient SatisfactionPenile ImplantationPenile IndurationPostoperative PeriodRetrospective StudiesSurveys and QuestionnairesTreatment OutcomeMicrobial Collagenase

Identifiers

PMID33420247
PMCPMC7794401
OpenAlexW3119577661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.